Table 2.
The distribution of neurologic deficit score in each group
| No. | Experimental groups | NDS in each groups (N) | Total(N) | Median | Premature death | Statistical results | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | 5 | |||||||
| 1 | Dose 0 | 1 | 2 | 6 | 8 | 1 | 0 | 18 | 2.5 | 2 | 1:2 sig. (0.000) | |
| 2 | Dose 50 | 7 | 8 | 3 | 0 | 0 | 0 | 18 | 1 | 0 | 1:3 sig. (0.000) | |
| 3 | Dose 75 | 7 | 9 | 2 | 0 | 0 | 0 | 18 | 1 | 0 | 1:4 sig. (0.000) | |
| 4 | Dose 100 | 8 | 10 | 0 | 0 | 0 | 0 | 18 | 1 | 1 | 3:4 nonsig. | |
| - | Total (N) | 23 | 29 | 11 | 8 | 1 | 0 | 72 | - | 3 | 2:3, 2:4nonsig. | |
NDS: neurologic deficit score; N: the number of cases in each group; sig: significant; nosing: non-significant.